STADA Australia is committed to improving the quality of life of patients, and supporting carers, though the provision of specialty products and support delivered by a compassionate, caring team of professionals.
For more than 120 years, STADA has been dedicated to supplying high-quality, innovative pharmaceutical products that help to improve the quality of life of patients.
STADA is a publicly traded, global pharmaceutical company with offices in more than 30 countries, including Germany, UK, Central Europe, Eastern Europe, Asia, Australia, and New Zealand.
Our individual market focus, facilitated through our international network of local marketing and sales companies, is an essential factor for our continued growth and success.
Around the world, STADA’s national markets have various product ranges.
About STADA Australia
STADA Australia is a speciality pharmaceutical company with a product focus on infusion therapies in Neurology and Pain Management.
We work closely with Britannia Pharmaceuticals in the UK, a wholly owned subsidiary of STADA, to ensure the latest innovative therapies and advancements in Europe are brought to Australia and New Zealand for Parkinson's disease.
In August 2016, STADA Australia and BioQ Pharma Incorporated announced a strategic partnership to commercialise three ready-to-use infusion pharmaceuticals in Australia and New Zealand for post-operative pain management.
BioQ Pharma is a specialty pharmaceutical company focused on setting a new standard of care for infusible drugs.
To be the leading specialty pharmaceutical company in Australia.
For all enquiries, please phone 1800 791 660 or email medinfo(at)stada.com.au